Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains

Published:2020-11-05 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Lee Chloe H.,Pinho Mariana Pereira,Buckley Paul R.,Woodhouse Isaac B.,Ogg Graham,Simmons Alison,Napolitani Giorgio,Koohy Hashem

Funder

Medical Research Council

Wellcome Trust

NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. Estimation of risk factors for COVID-19 mortality - preliminary results;Caramelo,2020

2. Demographic science aids in understanding the spread and fatality rates of COVID-19;Dowd;Proc Natl Acad Sci USA,2020

3. The trinity of COVID-19: immunity, inflammation and intervention;Tay;Nat Rev Immunol,2020

4. Estimates of the severity of coronavirus disease 2019: a model-based analysis;Verity;Lancet Infect Dis,2020

5. Cross-protective immunity to influenza A viruses;Epstein;Expert Rev Vaccines,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Effect of Influenza Vaccine on the Development of Symptoms in SARS-CoV-2 Infection and Outcome in Patients Hospitalized due to COVID-19;Vaccines;2024-07-12

2. Association between combination COVID-19-influenza vaccination and long COVID in middle-aged and older Europeans: A cross-sectional study;Human Vaccines & Immunotherapeutics;2024-05-09

3. Booster vaccination against the SARS-CoV-2: mechanisms and efficiency;Cardiovascular Therapy and Prevention;2024-02-08

4. In silicoassessment of immune cross protection between BCoV and SARS-CoV-2;2024-01-26

5. Effectiveness of influenza vaccination against coronavirus disease (COVID)-19 outcomes in hospitalized individuals in Brazil: an epidemiological study;Public Health;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3